Netcompany Group A/S
26.3.2026 18:04:23 CET | Globenewswire | Press release
Netcompany raises full-year margin guidance for 2026
Netcompany raises full-year margin guidance for 2026
Company announcement – inside information
No. 20/2026
26 March 2026
Netcompany raises full-year margin guidance for 2026
Netcompany’s continued focus on delivery excellence and implementation, supported by the ongoing embedding of AI capabilities into our methodology has led to increased expectation for adjusted EBITDA margin for the full-year 2026.
“As a leading European provider of complex IT solutions in regulated environments across public and private sectors, we constantly strive to become better at what we do.
The continuous investment over recent years in AI-embedded platforms and products and responsible AI executable methodology has positioned Netcompany as a European leader in delivering and/or renovating highly complex high-quality systems on time and within budget with reduced risk.
We are closely monitoring progress in these areas and finalising the first quarter of 2026 with a promising outlook. Based on current initiatives we see significant potential for accelerated and ongoing improvements as further initiatives are introduced throughout the Group.”
André Rogaczewski,
Netcompany CEO and Co-founder
For the full-year 2026, Netcompany now expects an adjusted EBITDA margin excluding Netcompany Banking Services (NBS) between 17% and 20% (previously between 16% and 19%). This implies an adjusted EBITDA margin including NBS between approximately 16% and 19% (previously between 15% and 18%).
Additional information
For additional information, please contact:
Netcompany Group A/S
Thomas Johansen, CFO, +45 51 19 32 24
Frederikke Linde, Head of IR, +45 60 62 60 87
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S24.10.2026 13:00:00 CEST | Press release
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
ASYAD24.10.2026 12:47:36 CEST | Press release
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
King Faisal Specialist Hospital & Research Centre24.10.2026 11:00:00 CEST | Press release
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
Orion Oyj24.10.2026 08:35:00 CEST | Press release
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
Zymeworks Inc.24.10.2026 08:30:00 CEST | Press release
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom